These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28940741)

  • 1. Hypermetabolism appears to be an adverse prognostic biomarker in amyotrophic lateral sclerosis: a potential for therapeutic intervention?
    Vucic S
    Eur J Neurol; 2018 Jan; 25(1):1-2. PubMed ID: 28940741
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis.
    Jésus P; Fayemendy P; Nicol M; Lautrette G; Sourisseau H; Preux PM; Desport JC; Marin B; Couratier P
    Eur J Neurol; 2018 Jan; 25(1):97-104. PubMed ID: 28940704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma creatinine: a potential prognostic biomarker in amyotrophic lateral sclerosis?
    Vucic S
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):119. PubMed ID: 29142144
    [No Abstract]   [Full Text] [Related]  

  • 4. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary: Amyotrophic lateral sclerosis: Ongoing search for prognostic biomarkers of longevity.
    Pandey S; Sarma N
    Neurol India; 2017; 65(5):1155-1156. PubMed ID: 28879922
    [No Abstract]   [Full Text] [Related]  

  • 6. Exploring microRNA Biomarker for Amyotrophic Lateral Sclerosis.
    Taguchi YH; Wang H
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29710810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein biomarkers for amyotrophic lateral sclerosis.
    Ryberg H; Bowser R
    Expert Rev Proteomics; 2008 Apr; 5(2):249-62. PubMed ID: 18466055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging molecular biomarker targets for amyotrophic lateral sclerosis.
    Costa J; de Carvalho M
    Clin Chim Acta; 2016 Apr; 455():7-14. PubMed ID: 26774696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis.
    Scarafino A; D'Errico E; Introna A; Fraddosio A; Distaso E; Tempesta I; Morea A; Mastronardi A; Leante R; Ruggieri M; Mastrapasqua M; Simone IL
    J Neurol; 2018 Oct; 265(10):2353-2362. PubMed ID: 30116940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further development of biomarkers in amyotrophic lateral sclerosis.
    Blasco H; Vourc'h P; Pradat PF; Gordon PH; Andres CR; Corcia P
    Expert Rev Mol Diagn; 2016 Aug; 16(8):853-68. PubMed ID: 27275785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylalanine hydroxylase: A biomarker of disease susceptibility in Parkinson's disease and Amyotrophic lateral sclerosis.
    Steventon GB; Mitchell SC
    Med Hypotheses; 2018 Sep; 118():29-33. PubMed ID: 30037610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics in amyotrophic lateral sclerosis: how far can it take us?
    Blasco H; Patin F; Madji Hounoum B; Gordon PH; Vourc'h P; Andres CR; Corcia P
    Eur J Neurol; 2016 Mar; 23(3):447-54. PubMed ID: 26822316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis.
    Su XW; Simmons Z; Mitchell RM; Kong L; Stephens HE; Connor JR
    JAMA Neurol; 2013 Dec; 70(12):1505-11. PubMed ID: 24145899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Apo B48 and other novel biomarkers in amyotrophic lateral sclerosis patient fibroblasts.
    Narayan M; Seeley KW; Jinwal UK
    Biomark Med; 2016 May; 10(5):453-62. PubMed ID: 27141953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia.
    Peter RS; Rosenbohm A; Dupuis L; Brehme T; Kassubek J; Rothenbacher D; Nagel G; Ludolph AC
    Eur J Epidemiol; 2017 Oct; 32(10):901-908. PubMed ID: 28975435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis.
    Patin F; Corcia P; Madji Hounoum B; Veyrat-Durebex C; Respaud E; Piver E; Benz-de Bretagne I; Vourc'h P; Andres CR; Blasco H
    Eur J Neurol; 2015 Oct; 22(10):1385-90. PubMed ID: 26095828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis.
    de Andrade HM; de Albuquerque M; Avansini SH; de S Rocha C; Dogini DB; Nucci A; Carvalho B; Lopes-Cendes I; França MC
    J Neurol Sci; 2016 Sep; 368():19-24. PubMed ID: 27538595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.
    Vu LT; Bowser R
    Neurotherapeutics; 2017 Jan; 14(1):119-134. PubMed ID: 27933485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.
    Gaiani A; Martinelli I; Bello L; Querin G; Puthenparampil M; Ruggero S; Toffanin E; Cagnin A; Briani C; Pegoraro E; Sorarù G
    JAMA Neurol; 2017 May; 74(5):525-532. PubMed ID: 28264096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of disease progression: a prognostic biomarker in ALS.
    Labra J; Menon P; Byth K; Morrison S; Vucic S
    J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):628-32. PubMed ID: 26152368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.